It doesn’t seem like there’s too much momentum for healthcare stocks, says Mizuho’s Jared Holz

October 24, 2023
It doesn’t seem like there’s too much momentum for healthcare stocks, says Mizuho’s Jared HolzIt doesn’t seem like there’s too much momentum for healthcare stocks, says Mizuho’s Jared Holz

Jared Holz, Mizuho healthcare sector specialist, joins ‘Squawk on the Street’ to discuss how Holz broadly sees the biotechnology sector, what distills the winners from losers in the healthcare space, and the innovation taking place in healthcare.

Share This

Latest Mizuho News

Selective opportunities in software stocks amid sell-off, says Mizuho’s Gregg Moskowitz

Selective opportunities in software stocks amid sell-off, says Mizuho’s Gregg Moskowitz

February 17, 2026
Eli Lilly has already won the weight loss drug battle, says Mizuho’s Jared Holz

Eli Lilly has already won the weight loss drug battle, says Mizuho’s Jared Holz

February 23, 2026
Polymarket settling with USDC helped drive our upgrade of Circle, says Mizuho’s Dan Dolev

Polymarket settling with USDC helped drive our upgrade of Circle, says Mizuho’s Dan Dolev

February 25, 2026

Mizuho news from around the globe

back-to-top-blue